Nitric oxide released from Swiss 3T3 fibroblasts acts as a cytostatic agent for cultured mast cells.
Nitric oxide (NO) released from Swiss 3T3 fibroblasts inhibited the proliferation of cultured mast cells (CMCs) on the CMCs/Swiss 3T3 fibroblast co-culture system. Swiss 3T3 fibroblasts produced NO upon treatment with recombinant interferon-gamma (rIFN-gamma). The production of NO was markedly increased by the co-treatment of rIFN-gamma and recombinant tumor necrosis factor-alpha. This production was dependent on L-arginine and could be inhibited by the competitive substrate inhibitor, L-arginine analogue NG-monomethyl-L-arginine (NGMMA). In addition, the number of CMCs increased when treated with NGMMA in the co-culture system. These findings indicate that the elevated production of NO from Swiss 3T3 fibroblasts during the co-culture inhibited the proliferation of CMCs.